L1 Capital’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-32,037
Closed -$3.18M 12
2022
Q1
$3.18M Buy
32,037
+6,276
+24% +$1.04M 0.38% 12
2021
Q4
$6.68M Hold
25,761
0.77% 14
2021
Q3
$7.03M Hold
25,761
0.87% 15
2021
Q2
$11M Hold
25,761
2.27% 10
2021
Q1
$9.92M Buy
+25,761
New +$11.6M 2.49% 10

Other funds holding DRIO

L1 Capital's DRIO Position: Q2 2022 in Review

L1 Capital sold out of DarioHealth (DRIO) in Q2 2022, closing a stake of 32,037 shares — an estimated $3.18M sold.

L1 Capital first reported a position in DRIO in Q1 2021 and held it in 5 quarters. The position peaked at $11M in Q2 2021. 58 funds tracked by Wall St. Rank hold DRIO as of Q2 2022.

  • L1 Capital reported no remaining DarioHealth position as of Q2 2022 after selling out during the quarter.
  • L1 Capital sold 32,037 DarioHealth shares in Q2 2022, an estimated $3.18M.
  • L1 Capital first reported a position in DarioHealth in Q1 2021 and held it in 5 quarters.
  • L1 Capital's DarioHealth position peaked at $11M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held DarioHealth as of Q2 2022.

Based on L1 Capital's 13F filing for Q2 2022, filed 15 Aug 2022.